The store will not work correctly when cookies are disabled.
1-Ethoxycarbonyl-4-benzyl-1,2,4-triazolo[4,3-a]quinoxaline
ID: ALA3621368
Cas Number: 261729-53-7
PubChem CID: 3756818
Max Phase: Preclinical
Molecular Formula: C19H16N4O2
Molecular Weight: 332.36
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: CCOC(=O)c1nnc2c(Cc3ccccc3)nc3ccccc3n12
Standard InChI: InChI=1S/C19H16N4O2/c1-2-25-19(24)18-22-21-17-15(12-13-8-4-3-5-9-13)20-14-10-6-7-11-16(14)23(17)18/h3-11H,2,12H2,1H3
Standard InChI Key: DJXQKAPQOGJRKP-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 28 0 0 0 0 0 0 0 0999 V2000
0.6426 0.8996 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.9460 0.1469 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9460 -1.3585 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.6426 -2.0562 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.6609 -1.3585 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.9460 -2.0562 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.2678 -1.3585 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.2678 0.1469 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.9460 0.8996 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.6609 0.1469 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4601 2.5335 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.0843 1.1566 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.9547 2.3683 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2280 -2.1383 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1945 -3.6387 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4749 -4.4202 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4385 -5.9197 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1216 -6.6380 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8412 -5.8566 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8776 -4.3571 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0501 3.4796 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4098 4.9082 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.2233 3.2273 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.5968 6.0215 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2290 7.1638 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 10 1 0
1 10 1 0
5 10 2 0
11 12 1 0
11 13 2 0
1 13 1 0
2 12 2 0
14 15 1 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
15 20 2 0
3 14 1 0
13 21 1 0
21 22 1 0
21 23 2 0
22 24 1 0
24 25 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 332.36 | Molecular Weight (Monoisotopic): 332.1273 | AlogP: 3.05 | #Rotatable Bonds: 4 |
Polar Surface Area: 69.38 | Molecular Species: NEUTRAL | HBA: 6 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 2.49 | CX LogD: 2.49 |
Aromatic Rings: 4 | Heavy Atoms: 25 | QED Weighted: 0.54 | Np Likeness Score: -1.00 |
References
1. Issa DAE, Habib NS, Abdel Wahab AE. (2015) Design, synthesis and biological evaluation of novel 1,2,4-triazolo and 1,2,4-triazino[4,3-a]quinoxalines as potential anticancer and antimicrobial agents, 6 (1): [10.1039/C4MD00257A] |